Device Energy

Enseal

Payments companies reported to CMS as associated with Enseal. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1.4Massociated payments (2023-2025)

3,097clinicians with associated payments

6companies reporting

By year

2023 $392K

2024 $400K

2025 $575K

Payments reported as associated with Enseal, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Surgery $494K

Colon & Rectal Surgery $273K

Obstetrics & Gynecology $190K

Thoracic Surgery (Cardiothoracic Vascular Surgery) $116K

Gynecology $51K

Gynecologic Oncology $48K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Enseal

These are the largest totals companies reported as associated with Enseal. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Kurian Thott	Stafford, VA	Obstetrics & Gynecology	$68,065.29
David Longcope	Denver, CO	Colon & Rectal Surgery	$63,062.04
John Lipham	Los Angeles, CA	Surgery	$45,530.00
Rahm Nazerali	Palo Alto, CA	Plastic Surgery	$44,631.73
Gina Adrales	Lutherville, MD	Surgery	$36,217.43
Jason Radecke	Sebastian, FL	Surgery	$36,014.35
Young Hong	Camden, NJ	Surgery	$31,065.00
Isaac Felemovicius	Maple Grove, MN	Colon & Rectal Surgery	$28,874.56
Sherief Shawki	Rochester, MN	Colon & Rectal Surgery	$28,055.00
Mehraneh Jafari	New York, NY	Colon & Rectal Surgery	$24,614.42

Prescribed Enseal?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.